Dominykas Milasius
Dominykas (Dom) Milašius is a DeepTech entrepreneur and investor, with a decade of previous experience in strategic and geopolitical risk advisory across EMEA. As a co-founder of Delta biosciences, he oversees commercial strategy across medchem and space chemistry verticals, including the radiation countermeasure testing in orbit. He is also a venture scout with BSV Ventures, a member of LitBAN and EBAN’s Space & Defence committee, and alumnus of the Paris Institute of Political Studies.
Delta Biosciences
Space Therapies: Accelerating Biotech Solutions for Health Beyond Earth
-
Space is among the harshest and least hospitable environments for humans. Every human biological system is affected by the space environment. The biological stress has a deleterious impact on health and physical capabilities, and the extreme conditions and isolation take a significant toll on mental performance and behavior. By 2040, hundreds of people will be in space at any given time, and more than 80% of those are predicted to be private citizens; for the reliability, safety, health, and enjoyment of those private participants, new solutions and therapeutics are needed to maintain health and wellbeing.
